 | • レポートコード：QYR9ST03693 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、神経皮膚障害の世界市場について調査・分析し、神経皮膚障害の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（結節性硬化症（TS）、神経線維腫症（NF）、スタージウェーバー症候群疾患、フォンヒッペルリンダウ病（VHL）、運動失調-毛細血管拡張症（A-T））、用途別（病院及び診療所、診断センター）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の神経皮膚障害市場動向 ・主要企業別マーケットシェア ・神経皮膚障害の種類別市場規模2014-2019 （結節性硬化症（TS）、神経線維腫症（NF）、スタージウェーバー症候群疾患、フォンヒッペルリンダウ病（VHL）、運動失調-毛細血管拡張症（A-T）） ・神経皮膚障害の用途別市場規模2014-2019 （病院及び診療所、診断センター） ・神経皮膚障害の北米市場：主要企業・種類別/用途別市場規模 ・神経皮膚障害のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・神経皮膚障害の中国市場：主要企業・種類別/用途別市場規模 ・神経皮膚障害の日本国内市場：主要企業・種類別/用途別市場規模 ・神経皮膚障害の東南アジア市場：主要企業・種類別/用途別市場規模 ・神経皮膚障害のインド市場：主要企業・種類別/用途別市場規模 ・神経皮膚障害の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Valeant Pharmaceuticals、Allergan、Syneron Medical、Medtronic、Cutera、St Jude Medical、Pfizer） ・神経皮膚障害の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Neurocutaneous Disorders are disorders that lead to growth of tumors in various parts of the body. They’re caused by the abnormal development of cells in an embryo and characterized by the tumors in various parts of the body (including the nervous system) and by certain differences in the skin. While some can be diagnosed at birth, others don’t produce symptoms until later in life. Although neurocutaneous disorders can’t be cured, treatments can help manage symptoms and any health problems that occur.Common neurocutaneous disorders that affect kids include neurofibromatosis, sturge-Weber syndrome, tuberous sclerosis (TS), ataxia-telangiectasia (A-T) and von Hippel-Lindau disease (VHL). Symptoms vary widely from condition to condition, and they affect different kids in different ways. Often, the full effects of these diseases — even if detected at birth — don’t emerge until a child grows up. The educational, social, and physical problems that the conditions cause must be managed throughout a child’s life.
In 2018, the global Neurocutaneous Disorder market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Neurocutaneous Disorder status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Neurocutaneous Disorder development in United States, Europe and China.
The key players covered in this study
Valeant Pharmaceuticals
Allergan
Syneron Medical
Medtronic
Cutera
St Jude Medical
Pfizer
…
Market segment by Type, the product can be split into
Tuberous Sclerosis (TS)
Neurofibromatosis (NF)
Sturge-Weber Syndrome Disease
Von Hippel-Lindau Disease (VHL)
Ataxia-Telangiectasia (A-T)
Market segment by Application, split into
Hospital & Clinics
Diagnostic Centers
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Neurocutaneous Disorder status, future forecast, growth opportunity, key market and key players.
To present the Neurocutaneous Disorder development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Neurocutaneous Disorder are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Neurocutaneous Disorder Market Size Growth Rate by Type (2014-2025)
1.4.2 Tuberous Sclerosis (TS)
1.4.3 Neurofibromatosis (NF)
1.4.4 Sturge-Weber Syndrome Disease
1.4.5 Von Hippel-Lindau Disease (VHL)
1.4.6 Ataxia-Telangiectasia (A-T)
1.5 Market by Application
1.5.1 Global Neurocutaneous Disorder Market Share by Application (2014-2025)
1.5.2 Hospital & Clinics
1.5.3 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Neurocutaneous Disorder Market Size
2.2 Neurocutaneous Disorder Growth Trends by Regions
2.2.1 Neurocutaneous Disorder Market Size by Regions (2014-2025)
2.2.2 Neurocutaneous Disorder Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Neurocutaneous Disorder Market Size by Manufacturers
3.1.1 Global Neurocutaneous Disorder Revenue by Manufacturers (2014-2019)
3.1.2 Global Neurocutaneous Disorder Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Neurocutaneous Disorder Market Concentration Ratio (CR5 and HHI)
3.2 Neurocutaneous Disorder Key Players Head office and Area Served
3.3 Key Players Neurocutaneous Disorder Product/Solution/Service
3.4 Date of Enter into Neurocutaneous Disorder Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Neurocutaneous Disorder Market Size by Type (2014-2019)
4.2 Global Neurocutaneous Disorder Market Size by Application (2014-2019)
5 United States
5.1 United States Neurocutaneous Disorder Market Size (2014-2019)
5.2 Neurocutaneous Disorder Key Players in United States
5.3 United States Neurocutaneous Disorder Market Size by Type
5.4 United States Neurocutaneous Disorder Market Size by Application
6 Europe
6.1 Europe Neurocutaneous Disorder Market Size (2014-2019)
6.2 Neurocutaneous Disorder Key Players in Europe
6.3 Europe Neurocutaneous Disorder Market Size by Type
6.4 Europe Neurocutaneous Disorder Market Size by Application
7 China
7.1 China Neurocutaneous Disorder Market Size (2014-2019)
7.2 Neurocutaneous Disorder Key Players in China
7.3 China Neurocutaneous Disorder Market Size by Type
7.4 China Neurocutaneous Disorder Market Size by Application
8 Japan
8.1 Japan Neurocutaneous Disorder Market Size (2014-2019)
8.2 Neurocutaneous Disorder Key Players in Japan
8.3 Japan Neurocutaneous Disorder Market Size by Type
8.4 Japan Neurocutaneous Disorder Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Neurocutaneous Disorder Market Size (2014-2019)
9.2 Neurocutaneous Disorder Key Players in Southeast Asia
9.3 Southeast Asia Neurocutaneous Disorder Market Size by Type
9.4 Southeast Asia Neurocutaneous Disorder Market Size by Application
10 India
10.1 India Neurocutaneous Disorder Market Size (2014-2019)
10.2 Neurocutaneous Disorder Key Players in India
10.3 India Neurocutaneous Disorder Market Size by Type
10.4 India Neurocutaneous Disorder Market Size by Application
11 Central & South America
11.1 Central & South America Neurocutaneous Disorder Market Size (2014-2019)
11.2 Neurocutaneous Disorder Key Players in Central & South America
11.3 Central & South America Neurocutaneous Disorder Market Size by Type
11.4 Central & South America Neurocutaneous Disorder Market Size by Application
12 International Players Profiles
12.1 Valeant Pharmaceuticals
12.1.1 Valeant Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Neurocutaneous Disorder Introduction
12.1.4 Valeant Pharmaceuticals Revenue in Neurocutaneous Disorder Business (2014-2019)
12.1.5 Valeant Pharmaceuticals Recent Development
12.2 Allergan
12.2.1 Allergan Company Details
12.2.2 Company Description and Business Overview
12.2.3 Neurocutaneous Disorder Introduction
12.2.4 Allergan Revenue in Neurocutaneous Disorder Business (2014-2019)
12.2.5 Allergan Recent Development
12.3 Syneron Medical
12.3.1 Syneron Medical Company Details
12.3.2 Company Description and Business Overview
12.3.3 Neurocutaneous Disorder Introduction
12.3.4 Syneron Medical Revenue in Neurocutaneous Disorder Business (2014-2019)
12.3.5 Syneron Medical Recent Development
12.4 Medtronic
12.4.1 Medtronic Company Details
12.4.2 Company Description and Business Overview
12.4.3 Neurocutaneous Disorder Introduction
12.4.4 Medtronic Revenue in Neurocutaneous Disorder Business (2014-2019)
12.4.5 Medtronic Recent Development
12.5 Cutera
12.5.1 Cutera Company Details
12.5.2 Company Description and Business Overview
12.5.3 Neurocutaneous Disorder Introduction
12.5.4 Cutera Revenue in Neurocutaneous Disorder Business (2014-2019)
12.5.5 Cutera Recent Development
12.6 St Jude Medical
12.6.1 St Jude Medical Company Details
12.6.2 Company Description and Business Overview
12.6.3 Neurocutaneous Disorder Introduction
12.6.4 St Jude Medical Revenue in Neurocutaneous Disorder Business (2014-2019)
12.6.5 St Jude Medical Recent Development
12.7 Pfizer
12.7.1 Pfizer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Neurocutaneous Disorder Introduction
12.7.4 Pfizer Revenue in Neurocutaneous Disorder Business (2014-2019)
12.7.5 Pfizer Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Neurocutaneous Disorder Key Market Segments
Table Key Players Neurocutaneous Disorder Covered
Table Global Neurocutaneous Disorder Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Neurocutaneous Disorder Market Size Market Share by Type 2014-2025
Figure Tuberous Sclerosis (TS) Figures
Table Key Players of Tuberous Sclerosis (TS)
Figure Neurofibromatosis (NF) Figures
Table Key Players of Neurofibromatosis (NF)
Figure Sturge-Weber Syndrome Disease Figures
Table Key Players of Sturge-Weber Syndrome Disease
Figure Von Hippel-Lindau Disease (VHL) Figures
Table Key Players of Von Hippel-Lindau Disease (VHL)
Figure Ataxia-Telangiectasia (A-T) Figures
Table Key Players of Ataxia-Telangiectasia (A-T)
Table Global Neurocutaneous Disorder Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital & Clinics Case Studies
Figure Diagnostic Centers Case Studies
Figure Neurocutaneous Disorder Report Years Considered
Table Global Neurocutaneous Disorder Market Size 2014-2025 (Million US$)
Figure Global Neurocutaneous Disorder Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Neurocutaneous Disorder Market Size by Regions 2014-2025 (Million US$)
Table Global Neurocutaneous Disorder Market Size by Regions 2014-2019 (Million US$)
Table Global Neurocutaneous Disorder Market Share by Regions 2014-2019
Figure Global Neurocutaneous Disorder Market Share by Regions 2014-2019
Figure Global Neurocutaneous Disorder Market Share by Regions 2019
Table Market Top Trends
Table Global Neurocutaneous Disorder Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Neurocutaneous Disorder Market Share by Manufacturers (2014-2019)
Figure Global Neurocutaneous Disorder Market Share by Manufacturers in 2018
Table Global Neurocutaneous Disorder Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Neurocutaneous Disorder Product/Solution/Service
Table Date of Enter into Neurocutaneous Disorder Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Neurocutaneous Disorder Market Size by Type (2014-2019) (Million US$)
Table Global Neurocutaneous Disorder Market Size Share by Type (2014-2019)
Figure Global Neurocutaneous Disorder Market Size Market Share by Type (2014-2019)
Table Global Neurocutaneous Disorder Market Size by Application (2014-2019) (Million US$)
Table Global Neurocutaneous Disorder Market Size Share by Application (2014-2019)
Figure Global Neurocutaneous Disorder Market Size Market Share by Application (2014-2019)
Figure Global Neurocutaneous Disorder Revenue Market Share by Application in 2018
Figure United States Neurocutaneous Disorder Market Size 2014-2019 (Million US$)
Table United States Key Players Neurocutaneous Disorder Revenue (2018-2019) (Million US$)
Table United States Key Players Neurocutaneous Disorder Market Share (2018-2019)
Table United States Neurocutaneous Disorder Market Size by Type (2014-2019) (Million US$)
Table United States Neurocutaneous Disorder Market Share by Type (2014-2019)
Table United States Neurocutaneous Disorder Market Size by Application (2014-2019) (Million US$)
Table United States Neurocutaneous Disorder Market Share by Application (2014-2019)
Figure Europe Neurocutaneous Disorder Market Size 2014-2019 (Million US$)
Table Europe Key Players Neurocutaneous Disorder Revenue (2018-2019) (Million US$)
Table Europe Key Players Neurocutaneous Disorder Market Share (2018-2019)
Table Europe Neurocutaneous Disorder Market Size by Type (2014-2019) (Million US$)
Table Europe Neurocutaneous Disorder Market Share by Type (2014-2019)
Table Europe Neurocutaneous Disorder Market Size by Application (2014-2019) (Million US$)
Table Europe Neurocutaneous Disorder Market Share by Application (2014-2019)
Figure China Neurocutaneous Disorder Market Size 2014-2019 (Million US$)
Table China Key Players Neurocutaneous Disorder Revenue (2018-2019) (Million US$)
Table China Key Players Neurocutaneous Disorder Market Share (2018-2019)
Table China Neurocutaneous Disorder Market Size by Type (2014-20189) (Million US$)
Table China Neurocutaneous Disorder Market Share by Type (2014-2019)
Table China Neurocutaneous Disorder Market Size by Application (2014-2019) (Million US$)
Table China Neurocutaneous Disorder Market Share by Application (2014-2019)
Figure Japan Neurocutaneous Disorder Market Size 2014-2019 (Million US$)
Table Japan Key Players Neurocutaneous Disorder Revenue (2018-2019) (Million US$)
Table Japan Key Players Neurocutaneous Disorder Market Share (2018-2019)
Table Japan Neurocutaneous Disorder Market Size by Type (2014-2019) (Million US$)
Table Japan Neurocutaneous Disorder Market Share by Type (2014-2019)
Table Japan Neurocutaneous Disorder Market Size by Application (2014-2019) (Million US$)
Table Japan Neurocutaneous Disorder Market Share by Application (2014-2019)
Figure Southeast Asia Neurocutaneous Disorder Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Neurocutaneous Disorder Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Neurocutaneous Disorder Market Share (2018-2019)
Table Southeast Asia Neurocutaneous Disorder Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Neurocutaneous Disorder Market Share by Type (2014-2019)
Table Southeast Asia Neurocutaneous Disorder Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Neurocutaneous Disorder Market Share by Application (2014-2019)
Figure India Neurocutaneous Disorder Market Size 2014-2019 (Million US$)
Table India Key Players Neurocutaneous Disorder Revenue (2018-2019) (Million US$)
Table India Key Players Neurocutaneous Disorder Market Share (2018-2019)
Table India Neurocutaneous Disorder Market Size by Type (2014-2019) (Million US$)
Table India Neurocutaneous Disorder Market Share by Type (2014-2019)
Table India Neurocutaneous Disorder Market Size by Application (2014-2019) (Million US$)
Table India Neurocutaneous Disorder Market Share by Application (2014-2019)
Figure Central & South America Neurocutaneous Disorder Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Neurocutaneous Disorder Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Neurocutaneous Disorder Market Share (2018-2019)
Table Central & South America Neurocutaneous Disorder Market Size by Type (2014-2019) (Million US$)
Table Central & South America Neurocutaneous Disorder Market Share by Type (2014-2019)
Table Central & South America Neurocutaneous Disorder Market Size by Application (2014-2019) (Million US$)
Table Central & South America Neurocutaneous Disorder Market Share by Application (2014-2019)
Table Valeant Pharmaceuticals Company Details
Table Valeant Pharmaceuticals Revenue in Neurocutaneous Disorder Business (2014-2019) (Million US$)
Figure Valeant Pharmaceuticals Revenue Growth Rate in Neurocutaneous Disorder Business (2014-2019)
Table Valeant Pharmaceuticals Recent Development
Table Allergan Company Details
Table Allergan Revenue in Neurocutaneous Disorder Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Neurocutaneous Disorder Business (2014-2019)
Table Allergan Recent Development
Table Syneron Medical Company Details
Table Syneron Medical Revenue in Neurocutaneous Disorder Business (2014-2019)(Million US$)
Figure Syneron Medical Revenue Growth Rate in Neurocutaneous Disorder Business (2014-2019)
Table Syneron Medical Recent Development
Table Medtronic Company Details
Table Medtronic Revenue in Neurocutaneous Disorder Business (2014-2019)(Million US$)
Figure Medtronic Revenue Growth Rate in Neurocutaneous Disorder Business (2014-2019)
Table Medtronic Recent Development
Table Cutera Company Details
Table Cutera Revenue in Neurocutaneous Disorder Business (2014-2019)(Million US$)
Figure Cutera Revenue Growth Rate in Neurocutaneous Disorder Business (2014-2019)
Table Cutera Recent Development
Table St Jude Medical Company Details
Table St Jude Medical Revenue in Neurocutaneous Disorder Business (2014-2019)(Million US$)
Figure St Jude Medical Revenue Growth Rate in Neurocutaneous Disorder Business (2014-2019)
Table St Jude Medical Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Neurocutaneous Disorder Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Neurocutaneous Disorder Business (2014-2019)
Table Pfizer Recent Development
Table Global Neurocutaneous Disorder Market Size by Regions (Million US$) 2019-2025
Figure Global Neurocutaneous Disorder Market Size Share by Regions (2019-2025)
Figure Global Neurocutaneous Disorder Market Size Share by Regions in 2025
Figure United States Neurocutaneous Disorder Market Size Forecast (2019-2025)(Million USD)
Figure Europe Neurocutaneous Disorder Market Size Forecast (2019-2025)(Million USD)
Figure China Neurocutaneous Disorder Market Size Forecast (2019-2025)(Million USD)
Figure Japan Neurocutaneous Disorder Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Neurocutaneous Disorder Market Size Forecast (2019-2025)(Million USD)
Figure India Neurocutaneous Disorder Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Neurocutaneous Disorder Market Size Forecast (2019-2025)(Million USD)
Table Global Neurocutaneous Disorder Market Size by Product (2019-2025) (Million US$)
Figure Global Neurocutaneous Disorder Market Size by Product (2019-2025)
Figure Global Neurocutaneous Disorder Market Size by Product in 2025
Table Global Neurocutaneous Disorder Market Size by Application (2019-2025) (Million US$)
Figure Global Neurocutaneous Disorder Market Size by Application (2019-2025)
Figure Global Neurocutaneous Disorder Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
筋萎縮性側索硬化症（ルーゲーリッグ病）治療の世界市場：市場規模・現状・予測 Amyotrophic Lateral Sclerosis (ALS) is a neurological disease that affects nerve cells in the brain and spinal cords which controls the activity of voluntary muscles. It is also termed as Lou Gehrig’s disease. There are several causes behind ALS which includes gene mutation, disorganized immune resp…- 自閉症スペクトラム障害診断及び治療の世界市場：市場規模・現状・予測 Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities. Over the past few years, with the increased number of infants an…
- 胃腸障害治療薬の世界市場：市場規模・現状・予測 Gastrointestinal disorder is mainly associated with the impairment of gastrointestinal functions that are affected mainly by contaminated or poisonous food. Gastrointestinal disorders includes irritable bowel syndrome, gastroesophageal reflux diseases and peptic ulcer diseases.Increasing incidences …
- 甲状腺障害の世界市場：市場規模・現状・予測 Thyroid disorders may lead to elevated or decreased levels of metabolic hormones, leading to medical conditions such as hypothyroidism, hyperthyroidism, etc. falling under the category of thyroid disorders. The global thyroid disorder market is estimated to be driven by the increasing prevalence of …
- 甲状腺障害の世界市場：市場規模・現状・予測 Thyroid disorders may lead to elevated or decreased levels of metabolic hormones, leading to medical conditions such as hypothyroidism, hyperthyroidism, etc. falling under the category of thyroid disorders. The global thyroid disorder market is estimated to be driven by the increasing prevalence of …